Praxis Precision Medicines (PRAX) Free Cash Flow (2019 - 2026)

Praxis Precision Medicines' Free Cash Flow history runs 8 years deep, the most recent figure standing at -$86.2 million for Q1 2026.

• In Q1 2026, Free Cash Flow fell 62.32% year-over-year to -$86.2 million; the TTM figure through Mar 2026 stood at -$282.2 million (down 72.1% YoY), while the FY2025 annual figure was -$249.1 million, down 89.08% from the prior year.
• Free Cash Flow was -$86.2 million for Q1 2026 at Praxis Precision Medicines, down from -$76.3 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of -$20.9 million in Q1 2024 to a low of -$86.2 million in Q1 2026.
• Historically, Free Cash Flow has averaged -$44.9 million across 5 years, with a median of -$44.5 million in 2022.
• The sharpest annual moves came in 2023 and 2025: Free Cash Flow surged 47.74% in 2023, then tumbled 154.47% in 2025.
• A 5-year view of Free Cash Flow shows it stood at -$29.2 million in 2022, then advanced by 18.42% to -$23.9 million in 2023, then tumbled by 135.2% to -$56.1 million in 2024, then sank by 36.0% to -$76.3 million in 2025, then retreated by 12.88% to -$86.2 million in 2026.
• The last three Free Cash Flow figures came in at -$86.2 million (Q1 2026), -$76.3 million (Q4 2025), and -$65.1 million (Q3 2025), per Business Quant data.